Dual-action therapies are rapidly evolving as a groundbreaking approach in the fight against both HIV and cancer. These treatments target several pathways within disease mechanisms, offering {a{ promise of improved efficacy and reduced side effects compared to traditional monotherapy approaches. By combining different therapeutic modalities, dual-a